AMI ORGANICS
|
AMI ORGANICS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 19.39 | 11.60 | 22.86 | 19.75 | 17.14 |
| CEPS(Rs) | 11.42 | 8.78 | 13.12 | 11.26 | 3.08 |
| DPS(Rs) | 1.50 | 3.00 | 3.00 | 3.00 | - |
| Book NAV/Share(Rs) | 159.95 | 182.13 | 163.01 | 143.34 | 51.03 |
| Tax Rate(%) | 25.79 | 40.53 | 25.75 | 21.33 | 24.72 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.05 | 17.91 | 19.88 | 20.22 | 23.53 |
| EBIT Margin(%) | 22.09 | 12.24 | 18.58 | 18.81 | 22.71 |
| Pre Tax Margin(%) | 21.47 | 11.42 | 18.19 | 17.58 | 21.06 |
| PAT Margin (%) | 15.93 | 6.79 | 13.50 | 13.83 | 15.85 |
| Cash Profit Margin (%) | 18.58 | 9.03 | 15.51 | 15.77 | 17.08 |
| Performance Ratios | |||||
| ROA(%) | 12.13 | 5.23 | 11.68 | 13.42 | 16.74 |
| ROE(%) | 16.19 | 7.70 | 14.92 | 21.07 | 40.51 |
| ROCE(%) | 20.14 | 11.81 | 20.45 | 23.85 | 33.43 |
| Asset Turnover(x) | 0.76 | 0.77 | 0.87 | 0.97 | 1.06 |
| Sales/Fixed Asset(x) | 1.78 | 1.84 | 2.33 | 2.40 | 2.27 |
| Working Capital/Sales(x) | 1.71 | 3.45 | 2.10 | 1.73 | 6.79 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.56 | 0.54 | 0.43 | 0.42 | 0.44 |
| Receivable days | 90.06 | 111.06 | 116.58 | 99.79 | 94.89 |
| Inventory Days | 61.02 | 70.18 | 68.46 | 60.54 | 60.39 |
| Payable days | 96.06 | 122.64 | 143.66 | 135.92 | 138.36 |
| Valuation Parameters | |||||
| PER(x) | 62.97 | 47.18 | 38.89 | 50.63 | - |
| PCE(x) | 106.87 | 62.32 | 33.87 | 44.41 | - |
| Price/Book(x) | 15.26 | 6.01 | 5.45 | 6.97 | - |
| Yield(%) | 0.06 | 0.27 | 0.34 | 0.30 | - |
| EV/Net Sales(x) | 19.61 | 5.85 | 5.16 | 6.81 | 0.49 |
| EV/Core EBITDA(x) | 79.31 | 30.88 | 25.09 | 32.83 | 2.03 |
| EV/EBIT(x) | 88.80 | 47.81 | 27.79 | 36.21 | 2.14 |
| EV/CE(x) | 14.99 | 4.71 | 5.33 | 6.77 | 0.56 |
| M Cap / Sales | 19.85 | 5.63 | 5.25 | 7.00 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 40.34 | 16.33 | 18.57 | 52.71 | 42.13 |
| Core EBITDA Growth(%) | 83.12 | 7.13 | 17.59 | 32.39 | 85.90 |
| EBIT Growth(%) | 153.16 | -23.34 | 17.09 | 26.52 | 91.73 |
| PAT Growth(%) | 229.35 | -41.52 | 15.77 | 33.24 | 96.57 |
| EPS Growth(%) | 67.16 | -49.26 | 15.77 | 15.18 | -34.48 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.32 | 0.01 | - | 0.85 |
| Current Ratio(x) | 3.91 | 1.73 | 2.81 | 3.32 | 1.30 |
| Quick Ratio(x) | 3.02 | 1.18 | 2.08 | 2.45 | 0.94 |
| Interest Cover(x) | 35.76 | 14.79 | 47.50 | 15.27 | 13.77 |
| Total Debt/Mcap(x) | - | 0.05 | - | - | - |
Compare Financial Ratios of peers of AMI ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMI ORGANICS | ₹13,793.6 Cr | -1.6% | -3.9% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
AMI ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMI ORGANICS | -1.6% |
-3.9% |
49.7% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses
